ArticleFrontiers in clinical diabetes and healthcare2026
Correction: Exploring factors predicting the effectiveness of oral semaglutide in Japanese individuals with type 2 diabetes switching from dipeptidyl peptidase 4 inhibitors: a pilot study.
Takao Hirotsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.